tiprankstipranks
Annovis Bio (DE:07X)
FRANKFURT:07X
Holding DE:07X?
Track your performance easily

Annovis Bio (07X) Income Statement

5 Followers

Annovis Bio Income Statement

Last quarter (Q3 2024), Annovis Bio's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Annovis Bio's net income was $-12.64M. See Annovis Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
-----$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 34.82M$ 45.04M$ 25.51M$ 14.54M$ 6.64M$ 870.55K
Operating Income
$ -34.82M$ -45.04M$ -25.51M$ -14.54M$ -6.64M$ -870.55K
Net Non Operating Interest Income Expense
$ 352.23K$ 667.90K$ 182.71K$ 13.34K$ 47.23K$ -40.93K
Other Income Expense
$ -6.85M$ 11.84M$ -182.71K$ -36.75K$ -1.13M$ -79.50K
Pretax Income
$ -33.44M$ -56.20M$ -25.33M$ -14.49M$ -5.46M$ -990.98K
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -33.44M$ -56.20M$ -25.33M$ -14.49M$ -5.46M$ -990.98K
Basic EPS
-----$ -0.17
Diluted EPS
-----$ -0.17
Basic Average Shares
-----$ 5.93M
Diluted Average Shares
-----$ 5.93M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 34.82M$ 45.04M$ 25.51M$ 14.54M$ 6.64M$ 870.55K
Net Income From Continuing And Discontinued Operation
$ -33.44M$ -56.20M$ -25.33M$ -14.49M$ -5.46M$ -990.98K
Normalized Income
$ -29.11M----$ -911.48K
Interest Expense
------
EBIT
$ -33.59M$ -56.20M$ -25.33M$ -14.49M$ -5.46M$ -870.55K
EBITDA
$ -33.59M$ -56.20M$ -25.33M$ -14.49M$ -5.46M$ -870.55K
Currency in USD

Annovis Bio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis